Improving Lymph Node Removal During Lung Cancer Surgery
Treatments studied
Part of Cancer, Lungs & breathing clinical trials.
This trial studies a better way to remove and examine lymph nodes from lung cancer surgery specimens. It aims to improve how doctors check for cancer spread, which may help guide your treatment after surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a lung nodule or mass that can be treated by removing an entire lobe of your lung (lobectomy).
- Your cancer has not spread to other parts of your body.
- Your lung nodule is on the outer edge of the lung (peripheral), not near the main airways.
- You are 18 years old or older.
- You have not had chemotherapy or radiation therapy before your lung surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at certain lymph nodes removed during surgery for non-small cell lung cancer (NSCLC) that has grown into the covering of the lung. The goal is to better understand lymph node involvement and help guide future treatment decisions.
This trial tests whether a more focused lymph node removal during surgery is safe and effective for people with a small, early-stage lung cancer (non-small cell type) located in the top part of the lung (apical segment).
This study looks at molecular (biologic) signals in the tumor and nearby lymph nodes after curative surgery for stage IIIA lung cancer. It may help doctors better understand the disease and improve future treatment planning.
This study tests a new way to decide which lymph nodes to remove during lung cancer surgery. The goal is to make surgery more precise and reduce side effects while still effectively removing cancer.
This trial compares two ways of removing lymph nodes during lung cancer surgery after you've had pre-surgery immunotherapy and chemotherapy. It aims to see if taking only a few key lymph nodes (instead of all of them) is just as effective and leads to fewer side effects.
This trial compares two ways of doing lung cancer surgery for early-stage tumors in the left lung. Some participants will have more lymph nodes removed (station 4L) and others will not, to see if the extra removal helps prevent the cancer from coming back.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.